Levetiracetam Stada

Levetiracetam, the active ingredient in Levetiracetam Stada, is an anticonvulsant presented as a tablet for oral use. It treats partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used in the management of epilepsy and related seizure disorders.

Partial seizures: reduces the frequency of focal onset seizures in patients with epilepsy. Generalized tonic‑clonic seizures: helps control convulsive episodes in generalized epilepsy. Myoclonic seizures: decreases the occurrence of brief, shock‑like muscle jerks in patients with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Fatigue: feeling unusually tired or low in energy. - Headache: mild to moderate head pain. - Irritability: increased mood lability. - Nausea: occasional upset stomach. - Somnolence: drowsiness or sleepiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Mood changes: depression or suicidal thoughts. - Stevens‑Johnson syndrome: severe skin blistering. - Blood dyscrasias: abnormal blood counts. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: toxic epidermal necrolysis.

Before prescribing Levetiracetam, clinicians should consider patient‑specific factors and monitor for potential risks.

Renal impairment: adjust dose based on renal function. Pregnancy: evaluate risk‑benefit as safety data are limited. Psychiatric history: monitor for mood alterations. Concomitant CNS depressants: observe for additive sedation. Elderly patients: start at lower dose and titrate cautiously. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levetiracetam may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels. - Phenobarbital: may reduce seizure control. - Phenytoin: potential decrease in levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression. - Other antiepileptics (e.g., valproate, lamotrigine): monitor seizure control and side‑effect profile. - Oral contraceptives: limited data, observe for hormonal changes.